Global Information
회사소개 | 문의 | 비교리스트

혈액은행 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Blood Bank Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2022년 01월 상품코드 995766
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,750 ₩ 6,364,000 PDF & Excel (Single User License)
US $ 5,250 ₩ 7,033,000 PDF & Excel (Team License: Up to 7 Users)
US $ 6,500 ₩ 8,708,000 PDF & Excel (Site License)
US $ 8,750 ₩ 11,723,000 PDF & Excel (Corporate License)


혈액은행 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Blood Bank Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 혈액은행 시장 규모는 2020년에 145억 5,000만 달러를 기록했습니다. 시장은 향후 5.2%의 CAGR로 확대되고, 2026년에는 197억 5,000만 달러에 달할 것으로 예측됩니다.

2020년 7월에 Annalsof Blood에 게재된 기사에 의하면 진행중인 팬데믹은 헬스케어 공급의 중요한 분야의 하나로, 즉 혈액 센터에서의 충분한 양의 안전하고 고품질인 혈액 확보에 심각한 영향을 미치고 있습니다. 혈액 대부분은 자발적인 무보수 헌혈자로부터 얻을 수 있었습니다. 모든 교육기관, 업계, 사회조직, IT 부문은 COVID-19 기간에 원격으로 활동하고 있습니다. 야외 헌혈 캠프는 주로 이러한 부문에 의해 조직되고 있으며, 이러한 조직의 폐쇄에 의해 헌혈이 감소했습니다. 따라서 현재 상황에서 확보할 수 있는 혈액에 한계가 있고, 이것이 시장 성장에 영향을 미칠 것으로 예상됩니다.

시장 성장을 추진하는 주요 요인에는 우발적인 증례 급증, 조혈계 질환의 높은 유병률 및 고령자 인구 증가가 있습니다. 2020년 2월에 세계보건기구가 발표한 조사에 의하면 세계에서는 매년 약 150만명이 교통사고로 사망했습니다. 교통사고에 의한 부상은 매년 국내 총생산의 3% 이상을 차지하고 있습니다. 도로의 부상과는 별도로, 우발적인 사건도 스포츠에서 급증하고 있습니다. 2020년 2월에 Sarah Megginson이 발표한 기사에 의하면 호주 성인의 89%가 매년 스포츠에 참여하고, 62%가 적어도 주에 3회 참여하고 있습니다. 또한 Australian Institute of Health and Welfare 2017에 의하면 스포츠를 하고있는 동안에 약 60,000명의 호주인이 부상 때문에 입원했다고 보고되고 있습니다. 따라서 이러한 사고 사례는 혈액 수요 증가에 기여할 것입니다. 또한 과거 몇 년간 수혈에 의한 전염성 감염증 만연, 수술, 헌혈에 대한 인식 확산과 함께 혈액 매개성 질환의 부담도 증가하고 있으며, 헌혈과 관련된 몇 가지 정부 정책이 혈액은행의 수요를 촉진하고, 시장 전체를 촉진하고 있습니다.

세계보건기구에 의하면 아동의 빈혈 유병률은 47.4%, 남성은 12.7%이며, 이것은 향후 몇 년간 세계에서 증가할 것으로 예상됩니다. 따라서 이 혈액장애의 부담 증가는 혈액이 널리 사용되는 조기 진단 및 치료의 수요를 급증시킬 것입니다. 따라서 이것이 혈액은행 시장 추진으로 이어질 것으로 보입니다.

세계의 혈액은행(Blood Bank) 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 은행 종류별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 추진력
    • 우발적인 증례 상승
    • 조혈계 질환의 높은 유병률
    • 혈액은행의 기술적 진보
  • 시장 성장 억제요인
    • 엄격한 규칙과 규제
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 제품별
    • 적혈구
    • 전혈
    • 혈소판
    • 백혈구
    • 혈장
  • 은행 종류별
    • 민간
    • 공영
  • 최종사용자별
    • 병원
    • 진단 센터
    • 외래 수술 센터
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동과 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • American Association of Blood Banks
    • Australian Red Cross
    • Bio-Rad Laboratories
    • Blood Bank of Alaska
    • Canadian Blood Services
    • Fresenius Kabi
    • Haemonetics
    • Maco Pharma
    • Ortho-Clinical
    • Teruma BCT
    • Vitalant

제7장 시장 기회와 동향

KSM 21.03.19

The blood bank market was valued at USD 14,550 million in 2020, and it is expected to reach USD 19,750 million in 2026, registering a CAGR of 5.20% during the forecast period, 2021-2026.

As per an article published on Annals of Blood in July 2020, the ongoing pandemic situation has seriously affected one significant area of healthcare delivery, i.e., the availability of an adequate quantity of safe and quality blood in blood centers. The majority of the blood comes from voluntary non-remunerated blood donors. All the educational institutions, industries, social organizations, and IT sectors have been working remotely during the COVID-19 period. Outdoor blood donation camps are mainly organized by these sectors, and the shutdown of these organizations has resulted in fewer blood donations. Thus, this limited availability of blood in the current situation is expected to affect the market growth.

The major factor propelling the growth of the market includes a steep rise in accidental cases, high prevalence of hematologic diseases, and an increasing geriatric population. According to a study published by the World Health Organization in February 2020, nearly 1.5 million people each year in the world die because of road traffic injuries. Road traffic injuries cost over 3% of the country's gross domestic product every year. Apart from the road injuries, accidental cases are also surging in sports. According to the article published by Sarah Megginson in February 2020, 89% of Australian adults participate in sports every year, with 62% participating at least three times a week. Furthermore, according to the Australian Institute of Health and Welfare 2017, it was reported that almost 60,000 Australians have been admitted to hospital for injuries while playing a sport. Hence, these cases of accidents will contribute to the increasing demand for blood. In addition, in the past few years, the burden of blood-borne diseases has also increased, coupled with the increasing prevalence of transfusion transmissible infection and surgeries, growing awareness about blood donation, and several government initiatives associated with blood donation, which are promoting the demand for blood banks and driving the overall market.

As per the World Health Organization, the prevalence rate of anemia in children is 47.4% and 12.7% in men, which is expected to rise in the coming years over the world. Thus, this increasing burden of blood disorder may drive the demand for early diagnosis and treatment wherein the blood has been widely used, resulting in the growth of the market.

Key Market Trends

The Red Blood Cells Segment is Estimated to Witness Healthy Growth in this Market

The red blood cells segment is expected to witness healthy growth over the forecast period. The growth of this segment is attributed to the high demand for transfusion, an increasing number of surgeries, a rising number of trauma cases, and an increasing prevalence of chronic disease-induced anemia. For instance, according to an article published by Michigan State University College of Human Medicine, on National Centers for Biotechnology Research in 2018, 50,000 to 100,000 new amputation surgeries are performed per year in the United States. Amputation surgeries are generally accompanied by transfusion of red blood cells; thus, the increasing trend in amputation surgeries is expected to drive the demand for red blood cell transfusion. In addition, as per the article published on the National Center of Biotechnology Information in July 2019, by the College of Medicine and Health Science, Ethiopia, the overall prevalence of anemia was found to be 41.1% in children of less than 5 years. Also, the advantages associated with red blood cells are easy availability, low cost of storage and maintenance, and the increasing demand in surgeries and transfusion, which are the major contributors to the segment growth.

However, the current COVID-19 scenario has had ramifications for ways of working of various surgical procedures. According to a study published by the World Health Organization in July 2020, it was found that that there is substantial financial and personnel changes in orthopedic and trauma surgery departments of hospitals, resulting in an average reduction of 49.4% in operating room capacity and an expected 29.3% loss of revenue in these departments. This decline in surgical procedures is expected to affect the overall growth of the market.

North America is Expected to Hold a Significant Share in the Market over the Forecast Period

North America is expected to hold a significant market share in the blood bank market due to the rising geriatric population, increasing incidences of blood disorders, and the rising number of trauma cases and surgical procedures. According to the statistics published by the United States Census Bureau, Population Projections, the number of Americans aged 65 and older is projected to double from 52 million in 2018 to 95 million by 2060, and it is estimated that this age group's share of the total population will rise from 16% to 23%. Also, as per American Red Cross, an estimated number of 36000 units of red blood cells is required every day, and nearly 7,000 units of platelets and approximately 10,000 units of plasma are needed each day in the United States. Over 21 million blood components are transfused each year in the United States.

In addition, as per the Centers for Disease Control and Prevention, hemophilia nearly affects 1 in 5000 male births and 400 newborn babies every year in the United States. Lymphoma, myeloma, leukemia, and myelodysplastic disorders are highly prevalent cancers. In the United States, on average, approximately every 3 minutes, at least one person is diagnosed with a type of blood cancer. This results in high demand for blood and boosts the blood bank market in this region. Furthermore, a large number of blood donations, well-established healthcare infrastructure, and government initiatives for blood donation in this region are fueling the market.

Competitive Landscape

The blood bank market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are Vitalant, New York Blood Center, The American National Red Cross, Australian Red Cross, America's Blood Centers, Canadian Blood Services, Japanese Red Cross Society, AABB, and Blood Bank of Alaska.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Accidental Cases
    • 4.2.2 High Prevalence of Hematologic Diseases
    • 4.2.3 Technological Advancements in Blood Banks
  • 4.3 Market Restraints
    • 4.3.1 Stringent Rules and Regulations
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Stringent Rules and Regulations
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Red Blood Cells
    • 5.1.2 Whole Blood
    • 5.1.3 Platelet
    • 5.1.4 White Blood Cells
    • 5.1.5 Plasma
  • 5.2 By Bank Type
    • 5.2.1 Private
    • 5.2.2 Public
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Ambulatory Surgical Centers
    • 5.3.4 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States (By Product, Bank Type, and End User)
      • 5.4.1.2 Canada (By Product, Bank Type, and End User)
      • 5.4.1.3 Mexico (By Product, Bank Type, and End User)
    • 5.4.2 Europe
      • 5.4.2.1 Germany (By Product, Bank Type, and End User)
      • 5.4.2.2 United Kingdom (By Product, Bank Type, and End User)
      • 5.4.2.3 France (By Product, Bank Type, and End User)
      • 5.4.2.4 Italy (By Product, Bank Type, and End User)
      • 5.4.2.5 Spain (By Product, Bank Type, and End User)
      • 5.4.2.6 Rest of Europe (By Product, Bank Type, and End User)
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China (By Product, Bank Type, and End User)
      • 5.4.3.2 Japan (By Product, Bank Type, and End User)
      • 5.4.3.3 India (By Product, Bank Type, and End User)
      • 5.4.3.4 Australia (By Product, Bank Type, and End User)
      • 5.4.3.5 South Korea (By Product, Bank Type, and End User)
      • 5.4.3.6 Rest of Asia-Pacific (By Product, Bank Type, and End User)
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC (By Product, Bank Type, and End User)
      • 5.4.4.2 South Africa (By Product, Bank Type, and End User)
      • 5.4.4.3 Rest of Middle-East and Africa (By Product, Bank Type, and End User)
    • 5.4.5 South America
      • 5.4.5.1 Brazil (By Product, Bank Type, and End User)
      • 5.4.5.2 Argentina (By Product, Bank Type, and End User)
      • 5.4.5.3 Rest of South America (By Product, Bank Type, and End User)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 American Association of Blood Banks
    • 6.1.2 Australian Red Cross
    • 6.1.3 Bio-Rad Laboratories
    • 6.1.4 Blood Bank of Alaska
    • 6.1.5 Canadian Blood Services
    • 6.1.6 Fresenius Kabi
    • 6.1.7 Haemonetics
    • 6.1.8 Maco Pharma
    • 6.1.9 Ortho-Clinical
    • 6.1.10 Teruma BCT
    • 6.1.11 Vitalant

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q